Last reviewed: July 17, 2026
Last updated: July 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
The Mounjaro KwikPen is a prefilled injection device designed to deliver tirzepatide, a dual GLP-1 and GIP receptor agonist approved for weight loss and diabetes management. Each pen holds enough medication for exactly four weekly injections, making dose tracking straightforward for patients starting their treatment journey. Knowing how many doses fit in one pen helps you plan refills and understand your monthly medication needs.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Many Doses Come In One Mounjaro KwikPen?
Each Mounjaro KwikPen contains four pre-measured doses of tirzepatide, designed for weekly self-injection over one month. The pen's cartridge holds 2.4 mg, 7.2 mg, or 15 mg total tirzepatide depending on the dosage strength prescribed by your provider. When you receive a 2.4 mg pen, for example, you administer 0.6 mg per week for four consecutive weeks before needing a new pen.
The four-dose design matches the typical dosing schedule tirzepatide follows during weight loss treatment. Each weekly injection delivers the same amount, ensuring consistent medication levels in your body throughout the month. Once all four doses are used, the pen is discarded and replaced with a new one from your pharmacy.
Understanding Tirzepatide Dose Progression and Pen Strength
Tirzepatide treatment typically begins at the lowest strength and increases gradually over several months as your body adjusts and your provider evaluates your response. Starting doses like 2.4 mg give your system time to adapt, while maintenance or higher doses may reach 10 mg or 15 mg depending on your individual needs and tolerance. Each pen strength is labeled clearly, so you always know exactly what dose you are injecting.
Your healthcare provider determines which pen strength you need based on your starting point, weight loss progress, and how well you tolerate the medication. The dose may increase at different intervals depending on whether tirzepatide is prescribed for weight management alone or combined with diabetes treatment. PlexusDx compounded tirzepatide injection is $289/mo month-to-month (or $249/mo on the 6-month plan), and your dose may need to go up—your price won't.
Preparing and Using Your Mounjaro Pen Correctly
Before each injection, remove your Mounjaro pen from the refrigerator and let it sit at room temperature for 15 to 30 minutes. Check the medication inside the window on the pen barrel—it should appear clear and colorless, without particles or discoloration. If the liquid looks cloudy or contains visible particles, do not use it and contact your pharmacy for a replacement.
To inject, pinch a fold of skin on your abdomen, thigh, or upper arm, insert the needle at a 90-degree angle, and press the injection button until you hear a click. Hold the needle in place for several seconds before removing it, then dispose of the used needle in a sharps container. Mark your calendar or set a phone reminder for the same day each week to maintain consistent timing between doses.
Why Compounded Tirzepatide From PlexusDx Offers Flexibility and Savings
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
PlexusDx serves all 50 states and accepts HSA and FSA funds, removing geographical barriers and financial obstacles to accessing tirzepatide treatment. Unlike branded pens with fixed dose increments, compounded formulations allow for smoother dose adjustments as your provider fine-tunes your therapy. Starting at $249 per month for compounded tirzepatide injection, PlexusDx delivers medical-grade peptide therapy at transparent, predictable pricing.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
How many injections do I get from one Mounjaro pen?
One Mounjaro KwikPen contains exactly four weekly doses. You administer one injection per week for four weeks, then replace the pen with a new one. This means one pen covers one full month of treatment.
What happens if I miss one of my four weekly doses from my pen?
If you miss a weekly injection, take it as soon as you remember within a few days. If it is almost time for your next scheduled dose, skip the missed dose and resume your normal schedule. Contact your healthcare provider if you frequently miss doses, as consistent weekly timing produces the best weight loss results.
Can I use the same Mounjaro pen for more or fewer than four injections?
No, Mounjaro pens are pre-filled to contain exactly four doses based on the labeled strength. Once all four doses are used, the pen must be discarded. Using extra medication from a pen or stretching it beyond four weeks is not recommended and may affect dosing accuracy.
How does PlexusDx compounded tirzepatide compare to brand-name Mounjaro pens?
PlexusDx compounded tirzepatide injections come from licensed 503A compounding pharmacies and offer dosing flexibility, transparent pricing at $289/mo month-to-month, or from $249/mo on the 6-month plan, and no insurance requirement. While brand-name Mounjaro pens are FDA-approved with fixed dose strengths, compounded versions allow your provider to customize doses and work with your genetic profile through optional Precision Peptide testing.
What does the Precision Peptide Genetic Test tell me about my tirzepatide response?
No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Am I Gaining Weight on Mounjaro? Insights for Women
Do Higher Doses of Mounjaro Cause More Weight Loss?